On April 13, both the Centers for Disease Control and Prevention and the United States Food and Drug Administration recommended a pause in the use of the Johnson & Johnson’s Janssen COVID-19…

On April 13, both the Centers for Disease Control and Prevention and the United States Food and Drug Administration recommended a pause in the use of the Johnson & Johnson’s Janssen COVID-19…
On February 5, the Food and Drug Administration held a public meeting to hear from consumer advocates, industry representatives and testing experts on the subject of testing methods implemented in the detection…